Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127335651 | 12733565 | 1 | I | 20160905 | 20160912 | 20160912 | EXP | PHHY2016CN124741 | NOVARTIS | HUIMING W, JIAXING G. CLINICAL ANALYSIS OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW. WEST CHINA JOURNAL OF STOMATOLOGY. 2016;34(4):358-63 | 64.00 | YR | F | Y | 0.00000 | 20160912 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127335651 | 12733565 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, QMO | U | 21223 | 4 | MG | SOLUTION FOR INJECTION | /month |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127335651 | 12733565 | 1 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127335651 | 12733565 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127335651 | 12733565 | Osteomyelitis | |
127335651 | 12733565 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |